Larotrectinib, a selective tropomyosin receptor kinase inhibitor for adult and pediatric tropomyosin receptor kinase fusion cancers. [electronic resource]
Producer: 20201104Description: 417-425 p. digitalISSN:- 1744-8301
- Adult
- Biomarkers, Tumor -- genetics
- Child
- Drug Resistance, Neoplasm -- genetics
- Humans
- Membrane Glycoproteins -- antagonists & inhibitors
- Molecular Targeted Therapy
- Neoplasms -- drug therapy
- Oncogene Proteins, Fusion -- genetics
- Protein Kinase Inhibitors -- therapeutic use
- Pyrazoles -- therapeutic use
- Pyrimidines -- therapeutic use
- Receptor, trkA -- antagonists & inhibitors
- Receptor, trkB -- antagonists & inhibitors
- Receptor, trkC -- antagonists & inhibitors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.